Michael A. Mussallem, Chairman & CEO at Edwards Lifesciences Corp (EW), sold 43,250 shares at $94.56 ($3.2M) on 2022-07-14, disclosed to the SEC on 2022-07-14.
Seasonal sale ($3.2M) by Chairman & CEO — this insider has traded EW in July in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 9,500 | $0 | 0.0% |
| 2 | $94.56 | 6,000 | $567K | 17.5% |
| 3 | $95.89 | 5,924 | $568K | 17.5% |
| 4 | $95.89 | 5,924 | $568K | 17.5% |
| 5 | $96.87 | 7,951 | $770K | 23.7% |
| 6 | $96.87 | 7,951 |
| $770K |
| 23.7% |
| Total | $75.00 avg | 43,250 | $3.2M | 100% |
| Filing → |
| EW | SELL | 2024-03-04 | $3.7M | — | Filing → |
| EW | SELL | 2024-02-05 | $5.0M | — | Filing → |
| EW | SELL | 2024-01-05 | $2.3M | — | Filing → |